TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial.

Heikki Joensuu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.